European Pharmaceutical Review
JANUARY 17, 2025
A new collaborative report provides best practice recommendations on using surrogate endpoints in health economic models to guide decisions about health technology assessment (HTA). The National Institute of Health and Care Excellence (NICE) explained that HTA bodies assess evidence on the short-term effects of a drug provided by companies and drug developers.
PQA
JANUARY 17, 2025
PQA has published anew reportdetailing technical recommendations for advancing health equity with PQA quality measures. Developed by the PQA Health Equity Technical Expert Panel (TEP), it provides key recommendations for PQA measure testing and use in quality programs. The TEP provided valuable health equity recommendations for PQA measure testing and use in quality programs, while also providing useful direction for future iterations of risk adjustment models.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
JANUARY 17, 2025
Researchers wanted to better understand the accuracy of advertising practices behind websites selling compounded GLP-1 RAs.
Pharmacy Times
JANUARY 17, 2025
If finalized, the requirement would include readily available nutrition information, including saturated fat, sodium, and added sugar content.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
JANUARY 17, 2025
A poll conducted by the Global Healthy Living Foundation found 11% of respondents with chronic conditions do not plan to get vaccinated for flu, COVID-19 or RSV.
Pharmacy Times
JANUARY 17, 2025
Acalabrutinib with bendamustine and rituximab shows efficacy in patients with untreated mantel cell lymphoma by increasing progression-free survival in the ECHO trial.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
JANUARY 17, 2025
These drugs are set to revolutionize their respective disease states in 2025.
PharmaVoice
JANUARY 17, 2025
Pharma dealmaking for drugs invented in China is putting pressure on U.S. biotechs to compete harder.
Pharmacy Times
JANUARY 17, 2025
Admissions to the hospital for fever were reduced in pediatric patients with medium-risk ALL receiving intravenous immunoglobulin, a potentially useful finding to help prevent infections in vulnerable patients.
PharmaVoice
JANUARY 17, 2025
There’s more to pharma's regulatory story in 2025 than just the IRA.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Fierce Healthcare
JANUARY 17, 2025
Healthcare recoveries were once again the lion's share of fiscal year 2024's $2.9 billion total. Law enforcement highlighted big-ticket settlements with Rite Aid, Community Health Network and Oak Street Health, among others.
Pharmacy Times
JANUARY 17, 2025
The authors note that future research will observe personality changes when psilocybin is used in patients with opioid-use disorder.
pharmaphorum
JANUARY 17, 2025
Hospitals should expand and speed up testing of people hospitalised with influenza to see if they are suffering from bird flu, says CDC.
Pharmacy Times
JANUARY 17, 2025
Pharmacies are actively working to address issues and support their patients by collaborative with regulatory bodies like the Board of Pharmacy, and their engagement with the local community.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmaceutical Technology
JANUARY 17, 2025
Shionogis S-892216 is being developed as a pre-exposure prophylaxis (PrEP) drug for Covid-19. Credit: seksan Mongkhonkhamsao via Getty Images.
Pharmacy Times
JANUARY 17, 2025
The report from the Office of Inspector General highlights inconsistencies, lack of transparency, and the need for stronger safeguards.
Fierce Healthcare
JANUARY 17, 2025
Only 61% of hospitals using AI or a predictive model report evaluating for accuracy using local data, and just 44% do so for bias, according to a recent study. Analyses suggest that hospitals with fewer resources are less likely to evaluate, leaving their patients at greater risk for harm.
pharmaphorum
JANUARY 17, 2025
Boehringer Ingelheim's bid to develop the first drug therapy for impaired cognitive function in schizophrenia looks like it has reached an end.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmacy Times
JANUARY 17, 2025
Christopher Herndon, PharmD, BCACP, FASHP, FCCP, CPE, discusses the upcoming BPS pain management certification launching in late 2025, its role in validating pharmacist expertise.
pharmaphorum
JANUARY 17, 2025
An AI can identify women who are at risk of experiencing a severe decline in cognitive function in menopause, which can be a risk factor for dementia.
Fierce Healthcare
JANUARY 17, 2025
The committee voted in favor of a draft recommendation to Congress that advocates for inpatient and outpatient increases as specified in current law plus an additional 1% in 2026. It also backed a $4 billion increase to a pool of funds for safety-net hospitals by adjusting how that money is distributed.
pharmaphorum
JANUARY 17, 2025
AstraZeneca's BTK inhibitor Calquence is the first drug in the class to be approved in the US for first-line treatment of mantle cell lymphoma.
Pharmacy Times
JANUARY 17, 2025
The FDA proposes to cap the nicotine level at 0.7 mg per gram of tobacco in cigarettes and certain other combusted tobacco products.
Pharmaceutical Commerce
JANUARY 17, 2025
In the second part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Donald Prentiss, founder and CEO, Qualthera, describes compounding pharmacies efforts in tackling the tirzepatide shortage, and dispels the notion that commercialized and compounded drugs are competing with one another.
Pharmacy Times
JANUARY 17, 2025
Compared with chemotherapy, Dato-DXd demonstrates favorable median progression-free survival and overall survival in a phase 3 clinical trial.
Pharmaceutical Technology
JANUARY 17, 2025
The Lonza CEO said the company is not under any pressure to exit the Capsules and Health Ingredients (CHI) business and is expecting strong interest for it.
Pharmacy Times
JANUARY 17, 2025
Pharmacies are increasingly viewed as wellness hubs and community health partners.
Pharmaceutical Technology
JANUARY 17, 2025
IMPACT Therapeutics has received the China NMPA marketing authorisation for Senaparib capsules in treating ovarian cancer.
Pharmacy Times
JANUARY 17, 2025
Data from the CodeBreaK 300 trial supported the FDA's approval.
Pharmaceutical Commerce
JANUARY 17, 2025
The latest news for pharma industry insiders.
Pharmacy Times
JANUARY 17, 2025
Despite the reductions in hepatitis B surface antigen (HBsAg), grade 3 and 4 adverse events were not uncommon.
Pharmaceutical Technology
JANUARY 17, 2025
The upcoming release of Phase III Fasenra data in COPD in 2025 is expected to solidify AstraZenecas position in the market.
pharmaphorum
JANUARY 17, 2025
Kardigan makes its debut with a teal of ex-MyoKardia execs and a $300m war chest, with a string of other biotechs also raising funds this week.
Expert insights. Personalized for you.
Let's personalize your content